| Parameters | |
| Mean age, yrs (±SD) | 63.8 (±8.81) | Sex/men, (%) | 133 (85%) | BMI, kg/m2 (±SD) | 27.1 (±3.10) | Prior MI, (%) | 56 (36%) | Anterior wall | 13 (8%) | Inferior wall | 32 (21%) | Posterior wall | 8 (5%) | Lateral wall | 6 (4%) | Hypertension, (%) | 98 (62%) | Hypercholesterolaemia, (%) | 157 (100%) | Killip class, (%) | | I | 157 (100%) | HR, min−1 (±SD) | 68.7 (±7.64) | BPsys, mmHg (±SD) | 131.8 (±12.20) | BPdias, mmHg (±SD) | 79.1 (±5.15) | Creatinine, umol/L (±SD) | 89.0 (±31.9) | MDRD, mL/min/1.73 m2 (±SD) | 74.2 (±14.7) | Hemoglobin, g/dL (±SD) | 13.56 (±1.98) | Hematocrit, % (±SD) | 39.4 (±6.90) | NT-pro BNP, ng/m (±SD) | 195.0 (±101.98) | 6MWT, m (±SD) | 443.0 (±58.51) | EF < 40%, (%) | 0 | LV > 5.6 cm, (%) | 0 | ASA, (%) | 155 (99%) | B-blockers, (%) | 154 (99%) | ACE-I, (%) | 144 (92%) | ARB, (%) | 4 (3%) | Diuretics, (%) | 20 (13%) | Inhibitors of aldosterone, (%) | 10 (6%) | Statins, (%) | 153 (98%) |
|
|